AllianceBernstein
SBBP

AllianceBernstein’s Strongbridge Biopharma plc. SBBP Stock Holding History

AllianceBernstein’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,700
Closed -$52K – 3506
2021
Q1 		$52K Hold
18,700
– – ﹤0.01% 3195
2020
Q4 		$45K Hold
18,700
– – ﹤0.01% 3148
2020
Q3 		$39K Hold
18,700
– – ﹤0.01% 3132
2020
Q2 		$71K Buy
+18,700
New +$56K ﹤0.01% 3135

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

AllianceBernstein's SBBP Position: Q2 2021 in Review

AllianceBernstein sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 18,700 shares — an estimated $52K sold.

AllianceBernstein first reported a position in SBBP in Q2 2020 and held it in 4 quarters. The position peaked at $71K in Q2 2020. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • AllianceBernstein reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • AllianceBernstein sold 18,700 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $52K.
  • AllianceBernstein first reported a position in Strongbridge Biopharma plc. in Q2 2020 and held it in 4 quarters.
  • AllianceBernstein's Strongbridge Biopharma plc. position peaked at $71K in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.